Alternative splicing of interleukin-33 and type 2 inflammation in asthma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 31, 2016, Pages 8765-8770

  Gordon, Erin D ^a   Simpson, Laura J ^b   Rios, Cydney L ^c   Ringel, Lando ^c   Lachowicz Scroggins, Marrah E ^a   Peters, Michael C ^a   Wesolowska Andersen, Agata ^c   Gonzalez, Jeanmarie R ^b   MacLeod, Hannah J ^a   Christian, Laura S ^b   Yuan, Shaopeng ^a   Barry, Liam ^a   Woodruff, Prescott G ^a,b   Ansel, K Mark ^b   Nocka, Karl ^d   Seibold, Max A ^c,e   Fahy, John V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

^d PFIZER INC   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 33; STEM CELL FACTOR RECEPTOR; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR GATA 2; IL1RL1 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN;

ALTERNATIVE RNA SPLICING; ASTHMA; BASOPHIL; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPLASM; EXON; FLOW CYTOMETRY; HUMAN; INFLAMMATION; KERATINOCYTE; MACROPHAGE; MAST CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM; RNA SEQUENCE; SPUTUM CULTURE; ADULT; CELL LINE; CYTOLOGY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; RESPIRATORY MUCOSA; SPUTUM; YOUNG ADULT;

ADULT; ALTERNATIVE SPLICING; ASTHMA; BASOPHILS; CELL LINE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; INTERLEUKIN-33; MALE; MAST CELLS; MIDDLE AGED; RESPIRATORY MUCOSA; SPUTUM; YOUNG ADULT;

EID: 84982684032     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1601914113     Document Type: Article

References (46)

1. Woodruff PG, et al. (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180(5):388-395.
2. Saenz SA, Taylor BC, Artis D (2008)Welcome to the neighborhood: Epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 226:172-190.
3. Kumar S, Minnich MD, Young PR (1995) ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1. J Biol Chem 270(46):27905-27913.
4. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN (2000) T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 191(6):1069-1076.
5. Oshikawa K, Yanagisawa K, Tominaga S, Sugiyama Y (2002) Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy 32(10):1520-1526.
6. Kondo Y, et al. (2008) Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 20(6):791-800.
7. Löhning M, et al. (1998) T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 95(12):6930-6935.
8. Ho LH, et al. (2007) IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J Leukoc Biol 82(6):1481-1490.
9. Smithgall MD, et al. (2008) IL-33 amplifies both Th1-And Th2-Type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20(8):1019-1030.
10. Bartemes KR, Kephart GM, Fox SJ, Kita H (2014) Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol 134(3):671-678.e4.
11. Nagarkar DR, et al. (2015) IL-13 mediates IL-33-dependent mast cell and type 2 innate lymphoid cell effects on bronchial epithelial cells. J Allergy Clin Immunol 136(1): 202-205.
12. Schmitz J, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-Associated cytokines. Immunity 23(5):479-490.
13. Poole A, et al. (2014) Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J Allergy Clin Immunol 133(3):670-8.e12.
14. McGrath KW, et al.; Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute (2012) A large subgroup of mild-To-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 185(6):612-619.
15. Bartemes KR, et al. (2012) IL-33-responsive lineage-CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 188(3):1503-1513.
16. Halim TY, et al. (2014) Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40(3): 425-435.
17. Van Dyken SJ, et al. (2014) Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and T cells. Immunity 40(3): 414-424.
18. Rickard JA, et al. (2014) RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis. Cell 157(5):1175-1188.
19. Jackson DJ, et al. (2014) IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit CareMed 190(12):1373-1382.
20. Tsuda H, et al. (2012) Novel splice variants of IL-33: differential expression in normal and transformed cells. J Invest Dermatol 132(11):2661-2664.
21. Kakkar R, Hei H, Dobner S, Lee RT (2012) Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 287(9):6941-6948.
22. Kouzaki H, Iijima K, Kobayashi T, O'Grady SM, Kita H (2011) The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-Type responses. J Immunol 186(7):4375-4387.
23. Byers DE, et al. (2013) Long-Term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest 123(9):3967-3982.
24. Snelgrove RJ, et al. (2014) Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J Allergy Clin Immunol 134(3):583-592.e6.
25. Allakhverdi Z, Smith DE, Comeau MR, Delespesse G (2007) Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179(4): 2051-2054.
26. Smith SG, et al. (2016) Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol 137(1):75-86.
27. Christianson CA, et al. (2015) Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol 136(1):59-68. e14.
28. Woodruff PG, et al. (2007) Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA 104(40):15858-15863.
29. Peters MC, et al. (2013) Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol 133(2):388-394.
30. Dobosy JR, et al. (2011) RNase H-dependent PCR (rhPCR): Improved specificity and single nucleotide polymorphism detection using blocked cleavable primers. BMC Biotechnol 11:80.
31. Liu X, et al. (2013) Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci USA 110(37):14918-14923.
32. Bhakta NR, et al. (2013) A qPCR-based metric of Th2 airway inflammation in asthma. Clin Transl Allergy 3(1):24.
33. Mjösberg J, et al. (2012) The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37(4):649-659.
34. Roussel L, Erard M, Cayrol C, Girard JP (2008) Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep 9(10):1006-1012.
35. Ali S, et al. (2011) The dual function cytokine IL-33 interacts with the transcription factor NF-?B to dampen NF-?B-stimulated gene transcription. J Immunol 187(4): 1609-1616.
36. Carriere V, et al. (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-Associated nuclear factor in vivo. Proc Natl Acad Sci USA 104(1):282-287.
37. Bessa J, et al. (2014) Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation. J Autoimmun 55:33-41.
38. Cohen ES, et al. (2015) Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nat Commun 6:8327.
39. Lefrançais E, et al. (2014) Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc Natl Acad Sci USA 111(43): 15502-15507.
40. Castanhinha S, et al. (2015) Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33. J Allergy Clin Immunol 136(2):312-22.e7.
41. Saglani S, et al. (2013) IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol 132(3):676-685.e13.
42. Dougherty RH, et al. (2010) Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J Allergy Clin Immunol 125(5):1046-1053.e8.
43. Busse W, et al. (2001) Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 108(2): 184-190.
44. Solèr M, et al. (2001) The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 18(2):254-261.
45. Loza MJ, et al.; ADEPT and U-BIOPRED Investigators (2016) Longitudinally stable, clinically defined clusters of patients with asthma independently identified in the ADEPT and U-BIOPRED asthma studies. Ann Am Thorac Soc 13(Suppl 1):S102-S103.
46. Choy DF, et al. (2015) TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med 7(301):301ra129.